BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 152144)

  • 1. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
    Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
    Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic markers of non-Hodgkin's lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Recent Results Cancer Res; 1978; 64():138-45. PubMed ID: 366692
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant lymphomas as tumours of the immune system.
    Berard CW; Cossman J; Jaffe ES
    Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
    Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
    Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine malignant lymphomas: comparison of morphologic and immunologic parameters.
    Holmberg CA; Manning JS; Osburn BI
    J Natl Cancer Inst; 1976 Jan; 56(1):125-35. PubMed ID: 768497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood B and T lymphocytes and in vitro cellular immune reactivity in untreated human malignant lymphomas and other malignant tumors.
    Heier HE; Klepp R; Gundersen S; Godal T; Normann T
    Scand J Haematol; 1977 Feb; 18(2):137-48. PubMed ID: 138931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.
    Said JW; Hargreaves HK; Pinkus GS
    Cancer; 1979 Aug; 44(2):504-28. PubMed ID: 383256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Lancet; 1976 Dec; 2(7999):1330-3. PubMed ID: 63805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.